Question 1

What is the catalog number for Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3?

Accepted Answer

The catalog number for Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3 is P1515-.5.

Question 2

What sizes are available for Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3?

Accepted Answer

Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3 is available in the following size(s): 500 µg.

Question 3

Is Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3 in stock?

Accepted Answer

Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Recombinant Rat Cytokine-induced Neutrophil Chemoattractant-2 alpha/CXCL3

Product Specifications

CAS Number

Field of Research

Purity

Molecular Weight

Shipping Conditions

Frequently Asked Questions

Explore Other Products

Axl Recombinant Rabbit Monoclonal Antibody [PSH06-68]

Anti-Daxx Antibody Picoband® (APC Conjugate)

Anti-HINT1 Antibody Picoband®

Human CLEC10A ELISA Kit PicoKine®, Carrier-free

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, 0.1mg/mL

CD44 / HCAM Std. (BU75), CF640R conjugate, 0.1mg/mL